Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascarenhas

Showing results (101-110 of 3,370) with videos related to

Pageof 337
Sort By:
Physical Review Letters|November 6, 1989
Polarized band-edge photoluminescence and ordering in Ga0.52In0.48PMascarenhas, Kurtz, Kibbler, et al.
BMJ (Clinical Research Ed.)|November 13, 1993
Hormone treatment for infertility. A chance for those who can't pay for IVFS Lee, L Mascarenhas
Plos One|April 6, 2023
Analysis of the medical residency matching algorithm to validate and improve equityBriance Mascarenhas, Kartikeye Puranam
The New England Journal of Medicine|June 7, 2002
Sporadic cases of hereditary systemic amyloidosisMaria João Mascarenhas Saraiva
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosisJohn Mascarenhas, Ronald Hoffman
Nutrition Reviews|March 5, 2004
New support for branched-chain amino acid supplementation in advanced hepatic failureRanjan Mascarenhas, Sohrab Mobarhan
Aesthetic Plastic Surgery|February 19, 2013
Refreshing labioplasty techniques for plastic surgeonsBassem Nathan, Lawrence Mascarenhas
BMJ Case Reports|June 5, 2013
Renal calculi in pregnancy? The role of ultralow-dose CTZachary Nash, Lawrence Mascarenhas
The Lancet. Haematology|May 21, 2022
Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intoleranceSangeetha Venugopal, John Mascarenhas
Expert Opinion on Pharmacotherapy|August 22, 2024
What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?Megan Metzger, John Mascarenhas
Pageof 337

Showing results (101-110 of 3,370) with videos related to

Sort By:
Pageof 337
Physical Review Letters|November 6, 1989
Polarized band-edge photoluminescence and ordering in Ga0.52In0.48PMascarenhas, Kurtz, Kibbler, et al.
BMJ (Clinical Research Ed.)|November 13, 1993
Hormone treatment for infertility. A chance for those who can't pay for IVFS Lee, L Mascarenhas
Plos One|April 6, 2023
Analysis of the medical residency matching algorithm to validate and improve equityBriance Mascarenhas, Kartikeye Puranam
The New England Journal of Medicine|June 7, 2002
Sporadic cases of hereditary systemic amyloidosisMaria João Mascarenhas Saraiva
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosisJohn Mascarenhas, Ronald Hoffman
Nutrition Reviews|March 5, 2004
New support for branched-chain amino acid supplementation in advanced hepatic failureRanjan Mascarenhas, Sohrab Mobarhan
Aesthetic Plastic Surgery|February 19, 2013
Refreshing labioplasty techniques for plastic surgeonsBassem Nathan, Lawrence Mascarenhas
BMJ Case Reports|June 5, 2013
Renal calculi in pregnancy? The role of ultralow-dose CTZachary Nash, Lawrence Mascarenhas
The Lancet. Haematology|May 21, 2022
Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intoleranceSangeetha Venugopal, John Mascarenhas
Expert Opinion on Pharmacotherapy|August 22, 2024
What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?Megan Metzger, John Mascarenhas
Pageof 337